Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro

eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleResearch Article: New Research, Disorders of the Nervous System

Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes

Andrew F. Scheyer, Milene Borsoi, Anne-Laure Pelissier-Alicot and Olivier J.J. Manzoni
eNeuro 31 August 2020, 7 (5) ENEURO.0144-20.2020; DOI: https://doi.org/10.1523/ENEURO.0144-20.2020
Andrew F. Scheyer
1Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale Unité 1249, Marseille, France
2Aix-Marseille University, France, 13273
3Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University, 13273
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milene Borsoi
1Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale Unité 1249, Marseille, France
2Aix-Marseille University, France, 13273
3Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University, 13273
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Laure Pelissier-Alicot
1Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale Unité 1249, Marseille, France
2Aix-Marseille University, France, 13273
3Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University, 13273
4Service de Psychiatrie, Assistance Public Hopitaux de Marseille, Centre Hospitalier Universitaire Conception, Marseille 13005, France
5Service de Médecine Légale, APHM, CHU Timone Adultes, Marseille 13005, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier J.J. Manzoni
1Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale Unité 1249, Marseille, France
2Aix-Marseille University, France, 13273
3Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University, 13273
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier J.J. Manzoni
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/ENEURO.0144-20.2020
PubMed 
32868310
Published By 
Society for Neuroscience
History 
  • Received April 10, 2020
  • Revision received July 9, 2020
  • Accepted July 27, 2020
  • Published online August 31, 2020.
Copyright & Usage 
Copyright © 2020 Scheyer et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Author Information

  1. Andrew F. Scheyer1,2,3,
  2. Milene Borsoi1,2,3,
  3. Anne-Laure Pelissier-Alicot1,2,3,4,5 and
  4. Olivier J.J. Manzoni1,2,3
  1. 1Institut de Neurobiologie de la Méditerranée, Institut National de la Santé et de la Recherche Médicale Unité 1249, Marseille, France
  2. 2Aix-Marseille University, France, 13273
  3. 3Cannalab Cannabinoids Neuroscience Research International Associated Laboratory, Institut National de la Santé et de la Recherche Médicale-Aix-Marseille University/Indiana University, 13273
  4. 4Service de Psychiatrie, Assistance Public Hopitaux de Marseille, Centre Hospitalier Universitaire Conception, Marseille 13005, France
  5. 5Service de Médecine Légale, APHM, CHU Timone Adultes, Marseille 13005, France
  1. Correspondence should be addressed to Olivier J. J. Manzoni at olivier.manzoni{at}inserm.fr.
View Full Text

Author contributions

  1. Author contributions: A.F.S., M.B., A.-L.P.-A., and O.J.J.M. designed research; A.F.S. and M.B. performed research; A.F.S. and M.B. analyzed data; A.F.S. and O.J.J.M. wrote the paper.

Disclosures

  • The authors declare no competing financial interests.

  • This work was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM), the INSERM-National Institutes of Health (NIH) Exchange Program (A.F.S.), the Fondation pour la Recherche Médicale Grant Equipe FRM 2015 (to O.J.J.M.), and the NIH Grant R01DA043982 (to O.J.J.M.).

Funding

  • HHS | NIH | National Institute on Drug Abuse (NIDA)

    R01DA043982
  • Fondation pour la Recherche Médicale (FRM)

    Equipe FRM 2015

Other Version

  • You are viewing the most recent version of this article.
  • previous version (August 31, 2020).

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2023-07-01
to
E.g., 2023-07-01

Article usage: August 2020 to May 2023

AbstractFullPdf
Aug 202024010
Sep 2020608198175
Oct 2020171485152
Nov 20204725749
Dec 20202927332
Total 20208791213418
Jan 20211411516
Feb 2021910313
Mar 2021147414
Apr 202185520
May 202136624
Jun 202165818
Jul 202148824
Aug 202156533
Sep 202125117
Oct 202177054
Nov 202106634
Dec 202116817
Total 202173879284
Jan 202234119
Feb 202224825
Mar 202214324
Apr 202204214
May 202206428
Jun 202216316
Jul 202213314
Aug 202213211
Sep 202242526
Oct 202243522
Nov 202254029
Dec 20225328
Total 202227498236
Jan 202333817
Feb 20233319
Mar 20231377
Apr 202305314
May 20231345
Total 2023819352
Total9872783990
Back to top

In this issue

eneuro: 7 (5)
eNeuro
Vol. 7, Issue 5
September/October 2020
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes
Andrew F. Scheyer, Milene Borsoi, Anne-Laure Pelissier-Alicot, Olivier J.J. Manzoni
eNeuro 31 August 2020, 7 (5) ENEURO.0144-20.2020; DOI: 10.1523/ENEURO.0144-20.2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Maternal Exposure to the Cannabinoid Agonist WIN 55,12,2 during Lactation Induces Lasting Behavioral and Synaptic Alterations in the Rat Adult Offspring of Both Sexes
Andrew F. Scheyer, Milene Borsoi, Anne-Laure Pelissier-Alicot, Olivier J.J. Manzoni
eNeuro 31 August 2020, 7 (5) ENEURO.0144-20.2020; DOI: 10.1523/ENEURO.0144-20.2020
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • accumbens
  • cannabinoid
  • lactation
  • perinatal
  • prefrontal cortex

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Research Article: New Research

  • β2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats
  • Running throughout Middle-Age Keeps Old Adult-Born Neurons Wired
  • Aβ-CT Affective Touch: Touch Pleasantness Ratings for Gentle Stroking and Deep Pressure Exhibit Dependence on A-Fibers
Show more Research Article: New Research

Disorders of the Nervous System

  • Sex and estrous cycle stage shape left-right asymmetry in chronic hippocampal seizures in mice
  • β2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats
  • Understanding Glaucoma One Synapse at a Time
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.